The international society of vascular behavioural and cognitive disorders: highlights from VasCog 2025 in the UK.
•AI-driven tools and multimodal biomarkers emerged as key for early VCID detection.•Novel neuroimaging, fluid, and retinal markers show promise for precision diagnostics.•BBB leakage and inflammation could early drive small vessel disease and VCID.•Clinical trials explore drug repurposing and hybrid lifestyle-pharmacological interventions.•Genetic insights into CADASIL reveal shared pathways with sporadic SVD.
Institutions
- Sunnybrook Health Science Centre (CA)
- Harvard University (US)
- Innsbruck Medical University (AT)
- St George's, University of London (GB)
- National University of Singapore (SG)
- Chinese University of Hong Kong (HK)
- SUNY Downstate Health Sciences University (US)
- University of Toronto (CA)
- Universität Innsbruck (AT)
- Erasmus MC (NL)
- Karolinska Institutet (SE)
- Department of Health and Aged Care (AU)
- Massachusetts General Hospital (US)
- National Cerebral and Cardiovascular Center (JP)
- Prince of Wales Hospital (CN)
- Hôpital Lariboisière (FR)
- Mayo Clinic in Arizona (US)
- MRC Unit for Lifelong Health and Ageing (GB)
- National University Health System (SG)
- University of Southampton (GB)
- University College London (GB)
Publication Details
- Journal
- Cerebral Circulation - Cognition and Behavior
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1016/j.cccb.2025.100525
- Primary Topic
- Cerebrovascular and genetic disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00